LETTER TO THE EDITOR
Year : 2008 | Volume
: 19 | Issue : 3 | Page : 455-
Author's reply
KVS Hari Kumar1, Arun Kumar2,
1 Department of Endocrinology, Medwin Hospitals, Chirag Ali Lane, Nampally, Hyderabad-500 001, India
2 Department of Nephrology, Army Hospital (R&R), New Delhi, India
Correspondence Address:
KVS Hari Kumar
Department of Endocrinology, Medwin Hospitals, Chirag Ali Lane, Nampally, Hyderabad-500 001
India
How to cite this article:
Hari Kumar K, Kumar A. Author's reply.Saudi J Kidney Dis Transpl 2008;19:455-455
|
How to cite this URL:
Hari Kumar K, Kumar A. Author's reply. Saudi J Kidney Dis Transpl [serial online] 2008 [cited 2021 Jan 24 ];19:455-455
Available from: https://www.sjkdt.org/text.asp?2008/19/3/455/40513 |
Full Text
To the Editor:
Thank you for good question and attention. First, second and fifth questions: many of patients received phosphate binders and calcium supplement, but we don't always able to goal according NKF DOQI guideline.
In these patients, normal calcium level was 8.5-10.5, and in the DGF group, the mean of calcium was a little more than other groups. Therefore, calcium level was within the normal range but upper limit of normal.
Third question: Underlying disorder in all of patients. This study included, hypertension 24.4%, diabetes 12.2%, ADPKD 7.6%, glomerulonephritis 3.8%, lupus nephritis 1.8%, others (trauma, reflux nephropathy, alports syndrome, nephrolithiasis and analgesic nephropathy) 6.3%, and finally unknown etiology was 43.2%.
Fourth question: yes that's right.
|
